Hepcidin increases the trapping of iron in the liver, making it unavailable to hematopoietic tissues and leading to a functional iron deficiency, which could explain the worsening anemia rates seen in patients that undergo RT [2–4, 13]. The gene discussed is HAMP; the disease is anemia.